"
Team:Grinnell/Project
From 2011.igem.org
(→Overall project) |
(→Overall project) |
||
| Line 7: | Line 7: | ||
== '''Overall project''' == | == '''Overall project''' == | ||
| - | Biofilms are cells encased in a hydrated extracellular polymeric substance (EPS) matrix that is composed of polysaccharides, proteins, nucleic acids, and lipids2. | + | Biofilms are cells encased in a hydrated extracellular polymeric substance (EPS) matrix that is composed of polysaccharides, proteins, nucleic acids, and lipids2. Biofilms act as a protective umbrella for their inhabitants against various adverse conditions <!--There's a word for that that I can't remember..-->and can aid in communication between cells3. Biofilms have recently become a concern in various fields, including health, food, and energy. The structure of biofilms make them difficult to remove once mature. By protecting the cells involved and facilitating horizontal gene transfer biofilms increase virulence of the incorporated bacteria. |
| - | + | Synthetic biologists are beginning to tackle the problem of biofilms, as evidenced by the number of iGEM teams interested in the degradation and inhibition of biofilms in recent years. These projects have been conducted using the workhorse of synthetic biology, ''E. coli'', with a focus on finding ways to kill the bacteria in the biofilm before the biofilm is formed (inhibition) or by infiltrating the biofilm (degradation). Our team approached this problem differently in two ways: we aimed to exploit the rigorous typeI secretion pathway of ''Caulobacter crescentus'', and we sought to degrade the EPS rather than kill the involved cells. | |
| - | + | We decided to utilize ''Caulobacter''<!--Use "Caulobacter" rather than "C. crescentus"--it's more common--> because it has many advatages over ''E. coli'' for our purposes. The first of these is the rigorous typeI secretion system that ''Caulobacter'' uses to secret its paracrystalline S-layer protein, RsaA, which makes up 10-12% of manufactured protein in lab strain CB15N (a strain which is deficient in producing a holdfast). ''Caulobacter'' is an aquatic bacterium, so it grows well in low-nutrient environments. Like ''E. coli'', ''Caulobacter'' is gram-negative and has had its genome sequence, however ''Caulobacter'' is safer for use around humans as it produces 100 times less endotoxin than ''E. coli'', and is unable to survive in a human body. | |
| + | <!--Sorry that I got rid of the citations, but they match up pretty well with the ones you had before--> | ||
| + | To exploit the secretion pathway, we planned to attach the C-terminal secretion tag from RsaA to a biofilm inhibiting or degrading protein. This allows our system to produce and secrete large quantities of enzyme that are easy to isolate because there is no cell lysis that is necessary. | ||
| - | For the biofilm | + | For the biofilm degrading enzymes that we chose to have ''Caulobacter'' secrete, we focused our efforts on a serine protease, Esp, from ''Staphylococcus epidermidis'', and a hydrolase, DspB, from ''Aggregatibacter actinomycetemcomitans'' that have both been shown to degrade biofilms8 9. |
| - | The general | + | The general goals of our project were: 1) to introduce ''Caulobacter'' as another potential chassis for synthetic biology, especially in environmental and biomedical-related fields; 2) to create a toolbox of biobrick parts that enable easy exploitation of ''Caulobacter's'' typeI secretion system for any protein of interest through fusion to the C-terminal secretion tag; 3) and to develop a system for degrading biofilms by targeting the EPS. |
== Project Details== | == Project Details== | ||
Revision as of 05:14, 28 September 2011
Project
Overall project
Biofilms are cells encased in a hydrated extracellular polymeric substance (EPS) matrix that is composed of polysaccharides, proteins, nucleic acids, and lipids2. Biofilms act as a protective umbrella for their inhabitants against various adverse conditions and can aid in communication between cells3. Biofilms have recently become a concern in various fields, including health, food, and energy. The structure of biofilms make them difficult to remove once mature. By protecting the cells involved and facilitating horizontal gene transfer biofilms increase virulence of the incorporated bacteria.
Synthetic biologists are beginning to tackle the problem of biofilms, as evidenced by the number of iGEM teams interested in the degradation and inhibition of biofilms in recent years. These projects have been conducted using the workhorse of synthetic biology, E. coli, with a focus on finding ways to kill the bacteria in the biofilm before the biofilm is formed (inhibition) or by infiltrating the biofilm (degradation). Our team approached this problem differently in two ways: we aimed to exploit the rigorous typeI secretion pathway of Caulobacter crescentus, and we sought to degrade the EPS rather than kill the involved cells.
We decided to utilize Caulobacter because it has many advatages over E. coli for our purposes. The first of these is the rigorous typeI secretion system that Caulobacter uses to secret its paracrystalline S-layer protein, RsaA, which makes up 10-12% of manufactured protein in lab strain CB15N (a strain which is deficient in producing a holdfast). Caulobacter is an aquatic bacterium, so it grows well in low-nutrient environments. Like E. coli, Caulobacter is gram-negative and has had its genome sequence, however Caulobacter is safer for use around humans as it produces 100 times less endotoxin than E. coli, and is unable to survive in a human body. To exploit the secretion pathway, we planned to attach the C-terminal secretion tag from RsaA to a biofilm inhibiting or degrading protein. This allows our system to produce and secrete large quantities of enzyme that are easy to isolate because there is no cell lysis that is necessary.
For the biofilm degrading enzymes that we chose to have Caulobacter secrete, we focused our efforts on a serine protease, Esp, from Staphylococcus epidermidis, and a hydrolase, DspB, from Aggregatibacter actinomycetemcomitans that have both been shown to degrade biofilms8 9.
The general goals of our project were: 1) to introduce Caulobacter as another potential chassis for synthetic biology, especially in environmental and biomedical-related fields; 2) to create a toolbox of biobrick parts that enable easy exploitation of Caulobacter's typeI secretion system for any protein of interest through fusion to the C-terminal secretion tag; 3) and to develop a system for degrading biofilms by targeting the EPS.
Project Details
